ENTRADA THERAPEUTICS, INC. (TRDA) Free cash flow 2020–2025
ENTRADA THERAPEUTICS, INC. (TRDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$129.6MFY2025 · since FY2020: -$27.9M → -$129.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.6M | -189.7% |
| FY2024 | -$44.7M | -133.3% |
| FY2023 | $134.2M | +238.8% |
| FY2022 | -$96.7M | -74.4% |
| FY2021 | -$55.4M | -98.8% |
| FY2020 | -$27.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice